Private Wealth Management Group’s Viking Therapeutics VKTX Stock Holding History

Private Wealth Management Group’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37K	Hold	112	–	–	﹤0.01%	899
2026 Q1	$3.65K	Sell	112 -130	-54%	-$4.18K	﹤0.01%	883
2025 Q4	$8.51K	Hold	242	–	–	﹤0.01%	563
2025 Q3	$6.36K	Hold	242	–	–	﹤0.01%	697
2025 Q2	$6.41K	Hold	242	–	–	﹤0.01%	649
2025 Q1	$5.84K	Buy	242 +130	+116%	+$4.11K	﹤0.01%	660
2024 Q4	$4.51K	Hold	112	–	–	﹤0.01%	785
2024 Q3	$7.09K	Hold	112	–	–	﹤0.01%	586
2024 Q2	$5.94K	Hold	112	–	–	﹤0.01%	641
2024 Q1	$9.18K	Hold	112	–	–	﹤0.01%	427
2023 Q4	$2.08K	Buy	+112	New	+$1.47K	﹤0.01%	963

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Private Wealth Management Group's VKTX Position: Q2 2026 in Review

Private Wealth Management Group held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 112 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Private Wealth Management Group first reported a position in VKTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.18K in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

Private Wealth Management Group held 112 shares of Viking Therapeutics worth $4.37K as of Q2 2026.
Private Wealth Management Group left its Viking Therapeutics share count unchanged in Q2 2026.
Viking Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #899 holding.
Private Wealth Management Group first reported a position in Viking Therapeutics in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Viking Therapeutics position peaked at $9.18K in Q1 2024.
432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.